Zero Shares Tendered in Novartis India Limited Open Offer as of June 17, 2026
The open offer concerning Novartis India Ltd. saw zero shares tendered in both demat and physical forms as of June 17, 2026. The offer sought to acquire up to 64,19,608 fully paidup equity shares representing 26% of the Voting Share Capital of the Target Company.The acquisition is being conducted by a consortium led by WaveRise Investments Limited, with participation from ChrysCapital Fund X and Two Infinity Partners. The collective entities acquiring the shares include Acquirer 1 (WaveRise Investments Limited), Acquirer 2 (ChrysCapital Fund X), and Acquirer 3 (Two Infinity Partners). The offer also includes two Persons Acting in Concert (PACs): ChrysCapital X, LLC and OceanEdge Investments Limited.
As per statements received by the Manager to the Open Offer on June 17, 2026, zero Equity Shares were tendered through the designated Open Offer Escrow Demat Account maintained with Ventura Securities Limited. Additionally, zero Equity Shares were tendered in physical form via the Registrar to the Open Offer.
The details of the shares tender status are summarized below:
| Tender Type | Date | Total Shares Tendered | Percentage of Offer Size |
|---|---|---|---|
| Demat Form (Escrow Account) | June 17, 2026 | NIL | NIL% |
| Physical Form | June 17, 2026 | NIL | NIL% |
The shares tendered by the Public Shareholders are subject to validation and verification of complete documentation. The Equity Shares that are validly tendered will be accepted in accordance with regulatory requirements.
NOVARTIND Stock Price Movement
Today, shares of Novartis India Limited rallied strongly after settling at ₹1,365.60, climbing 3.21% in the post-market session. The stock traded within an intraday range of ₹1,296 to ₹1,383.5 and saw a total volume of 13,589 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.